Alzamend Neuro Cash Flow Statement

Financials in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Oct '25 Oct 31, 2025	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021	2016 - 2020
Net Income	-5.83	-4.51	-9.95	-14.88	-12.36	-5.05	Upgrade
Depreciation & Amortization	0.08	0.05	0.05	0.02	0	-	Upgrade
Stock-Based Compensation	0.24	0.33	0.96	3.58	4.41	2.03	Upgrade
Other Operating Activities	-	0.01	0	-	0.01	0.45	Upgrade
Change in Accounts Payable	-0.54	-2.29	0.05	1.71	0.69	-0.41	Upgrade
Change in Other Net Operating Assets	0.4	-0.15	0.62	0.64	0.63	0.26	Upgrade
Operating Cash Flow	-5.65	-6.57	-8.27	-8.92	-6.61	-2.71	Upgrade
Capital Expenditures	-0.21	-0.3	-0.15	-	-0.11	-	Upgrade
Other Investing Activities	-	-	-	-	-	0.1	Upgrade
Investing Cash Flow	-0.21	-0.3	-0.15	-	-0.11	0.1	Upgrade
Short-Term Debt Issued	-	-	0.3	-	-	2.25	Upgrade
Total Debt Issued	-	-	0.3	-	-	2.25	Upgrade
Short-Term Debt Repaid	-	-	-	-	-0.06	-0	Upgrade
Total Debt Repaid	-	-	-	-	-0.06	-0	Upgrade
Net Debt Issued (Repaid)	-	-	0.3	-	-0.06	2.25	Upgrade
Issuance of Common Stock	1.53	2.7	1.25	0	18.91	2.2	Upgrade
Financing Cash Flow	6.21	10.44	3.65	0	18.85	4.45	Upgrade
Net Cash Flow	0.36	3.57	-4.76	-8.92	12.13	1.84	Upgrade
Free Cash Flow	-5.86	-6.87	-8.42	-8.92	-6.72	-2.71	Upgrade
Free Cash Flow Per Share	-3.40	-15.24	-111.97	-123.53	-101.83	-50.40	Upgrade
Levered Free Cash Flow	-3.7	-5.19	-4.69	-4.33	-2.19	-0.41	Upgrade
Unlevered Free Cash Flow	-3.7	-5.17	-4.68	-4.33	-2.16	-0.31	Upgrade
Change in Working Capital	-0.14	-2.44	0.67	2.35	1.33	-0.15	Upgrade

Updated Oct 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q